The study, known as THERAC, was conducted at the Léon Bérard Cancer Center in Lyon, one of France’s designated comprehensive cancer centers. Rather than relying on retrospective surveys or patient recall, the researchers collected data prospectively, using clinician-rated assessments at three fixed time points: at the moment of inclusion in the study, three months later, and six months later. This design matters because it captures the consultation process as it unfolds in routine clinical practice, not as patients remember it months or years afterward. Fifty patients attended an integrative oncology consultation during the study period, and their characteristics, requests, and referral pathways were systematically documented.

The demographic profile of the patients was strikingly skewed. Forty-five of the fifty attendees, or ninety percent, were women, and more than half, twenty-eight patients or fifty-six percent, were living with breast cancer. Twenty-two patients, forty-four percent, came from the wealthier metropolitan areas surrounding the center. These figures echo a persistent pattern documented across the complementary and alternative medicine literature: the patients who reach structured integrative oncology services are disproportionately female, disproportionately treated for breast cancer, and disproportionately drawn from more affluent, urban populations. The authors situate this within a broader body of French and international research on health inequalities, including studies showing that access to early-phase clinical trials in oncology is similarly shaped by social and geographic factors.

What did these patients actually want? The study recorded their motivations in detail, and the answers reveal a population seeking holistic engagement rather than a single miracle remedy. Thirty-seven patients, seventy-four percent, expressed a desire for comprehensive support, meaning they wanted their care considered as a whole rather than in fragments. Thirty-four patients, sixty-eight percent, said they wanted to improve their overall well-being, and thirty-three, sixty-six percent, specifically hoped to reduce the side effects of their cancer treatment. These motivations align with what previous systematic reviews have found: cancer patients typically turn to complementary approaches not to replace conventional medicine but to feel better while undergoing it, and often without telling their oncologists what they are doing.

That last point, the disclosure gap, is one of the most consequential findings in the wider field. Research cited by the THERAC team, including a systematic review of cancer patient disclosure and physician communication about complementary medicine use, has shown that many patients keep their use of supplements, herbal products, and alternative practitioners hidden from their medical teams. This silence is not trivial. Some herbal products and supplements can interact with chemotherapy or hormonal therapies, and unmonitored use can create genuine clinical risk. The integrative oncology consultation, in this framework, functions as a safe disclosure channel: a dedicated hour in which patients can talk openly about everything they are doing or considering, with a clinician trained to distinguish evidence-supported supportive practices from potentially harmful ones.

The structure of the consultation itself emerged clearly from the data. For forty of the fifty patients, or eighty-two percent, the first integrative oncology consultation lasted a full sixty minutes, an unusually generous allocation of time by the standards of modern oncology visits. Within that hour, clinicians most frequently prescribed aromatherapy, doing so for thirty-five patients, or seventy-four percent of those assessed. Aromatherapy has been progressively implemented at the Léon Bérard center in recent years, and the THERAC data suggest it has become the workhorse of the institution’s integrative offerings, typically deployed against anxiety, nausea, sleep disturbance, and other treatment-related symptoms.

Referral to other supportive care services was equally central to the consultation’s function. Twenty-four patients, sixty-nine percent, were oriented toward psychological support, and twenty-two patients, sixty-three percent, were directed toward adapted physical activities, structured exercise programs tailored to patients’ capacities during and after cancer treatment. These referrals are significant because both psychological support and physical activity sit at the top of the evidence hierarchy in integrative oncology. The Society for Integrative Oncology and the American Society of Clinical Oncology have jointly issued clinical practice guidelines endorsing specific mind-body and exercise interventions for anxiety, depression, and other symptoms in adults with cancer, and the Lyon consultation appears to operate as a routing mechanism that connects patients to precisely these guideline-supported services rather than leaving them to navigate the wellness marketplace alone.

Patient satisfaction with the process was remarkably high across the follow-up period. At the three-month assessment, twenty-seven of twenty-nine responding patients, ninety-three percent, reported being satisfied with the integrative oncology consultation. By six months, satisfaction among the eleven patients still responding was one hundred percent. The declining number of respondents at later time points is a familiar limitation of longitudinal observational studies, and the authors are candid that the sample is small and drawn from a single center, which constrains how far the findings can be generalized. Still, the consistency of positive evaluations suggests that the consultation model, with its long format and multidisciplinary referral capacity, meets a real and previously unmet need among the patients who access it.

Perhaps the most sobering conclusion of the study concerns equity and infrastructure. The authors found that referral to complementary therapies depended heavily on institutional resources and on the network connecting the cancer center to the surrounding city and hospital system. In other words, what a patient receives after an integrative oncology consultation is not determined solely by clinical need but by what services happen to exist locally and whether the institution has the staff and partnerships to deliver them. Combined with the observation that attendees were mostly women with breast cancer from affluent metropolitan areas, this points to a double filter: patients with time, information, and proximity are more likely to reach the consultation in the first place, and the services they are then referred to vary by geography and institutional capacity.

The THERAC team argues that a more transparent framework is needed for integrative oncology, one that provides appropriate management, ensures quality control, and limits potential abuses in a field where commercial interests often outpace the evidence. Their data sketch what such a framework looks like in practice: a dedicated consultation of about an hour, clinician-rated follow-up at fixed intervals, prescriptions restricted to therapies with supportive evidence such as aromatherapy, and active referral into psychological care and adapted physical activity. As demand for complementary approaches among cancer patients continues to grow worldwide, the Lyon experience suggests that the central challenge is not whether to offer integrative oncology, but how to build it so that the patients who need it most, not only those best positioned to ask for it, can reach it.

Subject of Research: Integrative oncology consultations and referral pathways to complementary therapies for cancer patients

Article Title: Integrative oncology consultation and patient referral to complementary therapies: results from the prospective study THERAC

Article References: Lochmann, M., Girodet, M., Charton, E., Bouvier, C., Fayet, Y., Fuentes-Vallejo, M., Chvetzoff, G., Christophe, V., & Mastroianni, B. (2026). Integrative oncology consultation and patient referral to complementary therapies: results from the prospective study THERAC. Supportive Care in Cancer, 34(10), Article 970. https://doi.org/10.1007/s00520-026-11217-5

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11217-5

Keywords: integrative oncology, complementary therapies, supportive care, cancer, aromatherapy, breast cancer, patient referral, health inequalities, psychological support, adapted physical activity, prospective study, quality of life

The study, known as APAMAdom, was conducted by a team of French researchers led by Béatrice Genoux of Grenoble Alpes University Hospital and Cécile Bétry, with collaborators including Sébastien Guillaume of Montpellier University Hospital. It tested whether a home-based adapted physical activity program delivered entirely by videoconference could be safe and acceptable for adult women with anorexia nervosa being treated as outpatients. The trial was registered on ClinicalTrials.gov as NCT05803707 and approved by a French ethics committee, the CPP Sud-Ouest et Outre-Mer II in Toulouse, and all participants gave written informed consent before enrollment.

The design was deliberately pragmatic. Adult women aged 18 to 60 with anorexia nervosa and a body mass index below 18.5 kilograms per square meter were recruited through two specialized eating disorder centers attached to French university hospitals. The program itself consisted of ten sessions in total, of which eight were weekly 45-minute adapted physical activity sessions led by qualified instructors over video. Researchers tracked a broad set of outcomes before and after the program, including body weight, body composition, physical activity levels, exercise dependence, quality of life, and self-esteem. Because this was a pilot study, the results were reported descriptively, with pre-to-post comparisons carried out using a paired Wilcoxon signed-rank test, a non-parametric method suited to small samples.

Thirty-six women ultimately enrolled, and their profiles underscore how severe the illness can be in this population. The median age was 33 years, with an interquartile range of 26 to 47. The median body mass index was just 15.6 kilograms per square meter, well below the diagnostic threshold for anorexia, and the median duration of illness was a striking ten years, with some participants having lived with the disorder for up to seventeen years. These were not people at the margins of the illness; they were women in its deep chronic phase, precisely the group for whom outpatient options are scarcest.

The safety findings are the study’s most reassuring contribution. Throughout the program, body weight, body composition, physical activity levels, and exercise dependence all remained stable. Only one participant was withdrawn from the study, and that was due to weight loss exceeding five percent of her baseline body weight, a pre-specified safety threshold. No other adverse pattern emerged. For a therapy involving deliberate physical movement in patients with dangerously low body weight, that stability matters enormously, because the central clinical fear has always been that exercise interventions could inadvertently fuel weight loss or reinforce compulsive activity.

Satisfaction, meanwhile, ran high. Among the 22 participants who responded to the satisfaction assessment, 77.3 percent said they wished to continue the program. That figure is notable given the population involved: patients with anorexia nervosa often avoid or drop out of interventions that touch on the body, and the therapeutic relationship around exercise is fraught. The fact that most women wanted more sessions suggests that the videoconference format, far from feeling impersonal, may have created a comfortable middle ground between clinical supervision and domestic privacy.

The participation data, however, tell a more complicated and arguably more valuable story. Of 66 eligible participants, only 36.4 percent completed the first session, a measure the researchers call the initial uptake rate. Among the 36 women who enrolled, just five, or 13.9 percent, completed all ten sessions. The retention rate for the end-of-program visit was 63.9 percent. These numbers are sobering, but they are exactly the kind of real-world estimates that pilot studies exist to produce. A future randomized controlled trial can now be sized and structured with realistic expectations about how many patients will start such a program and how many will see it through, rather than with the optimistic assumptions that have undermined many behavioral interventions.

Beneath the headline numbers, there were hints of genuine psychological benefit. The researchers observed medium effect sizes suggesting improvement in quality of life, with a correlation coefficient of r = 0.40, and in self-esteem, with r = 0.36. In a study of this size, such differences are too small to draw firm conclusions, and the authors are careful to say so. But the direction of the effects is consistent with what inpatient adapted physical activity programs have reported, and it gives the proposed primary outcome for the future trial, quality of life, a plausible empirical footing. If a supervised movement program can lift self-esteem in women whose relationship with their bodies is profoundly damaged, without shifting weight in either direction, that would be a meaningful therapeutic gain in its own right.

The technological dimension of the study deserves attention in its own right. Telehealth expanded explosively during the COVID-19 pandemic, but mental health applications for eating disorders have lagged, partly because clinicians worried that remote formats would weaken the monitoring that keeps vulnerable patients safe. APAMAdom offers a counterexample: a structured, video-supervised intervention with explicit safety thresholds, delivered by instructors employed through a home healthcare provider, that maintained weight stability in a severely ill cohort. The funding structure is also worth noting. The study was financed by an Innovadom grant from the Agiradom association, a home healthcare provider whose instructors collected the data, but the funder had no role in the conceptualization, design, analysis, decision to publish, or preparation of the manuscript, and the authors disclose only modest honoraria and hospitality fees.

What emerges from APAMAdom is less a triumph than a blueprint, and that is precisely its value. The study demonstrates that a home-based, video-supervised adapted physical activity program is feasible, safe, and wanted by the patients who try it, while honestly documenting the attrition that any larger trial must plan around. For the millions of people worldwide living with anorexia nervosa, most of whom will never set foot in a specialized inpatient unit, the prospect of receiving structured movement therapy at home, through a screen, with a qualified instructor watching over them, represents a genuine widening of the treatment map. The randomized controlled trial that the researchers now propose, with quality of life as its primary endpoint, will determine whether that promise holds. But the first, most dangerous question, whether exercise therapy can be delivered safely outside the hospital walls, has now been answered with a cautious yes.

Subject of Research: Home-based video-supervised adapted physical activity for adult women with anorexia nervosa

Article Title: A home-based video-supervised adapted physical activity program in adult women with anorexia nervosa: a pilot study

Article References: Genoux, B., Guillaume, S., Buis, C., Bakouline, M. C., Bosson, J.-L., & Bétry, C. (2026). A home-based video-supervised adapted physical activity program in adult women with anorexia nervosa: a pilot study. Journal of Eating Disorders. https://doi.org/10.1186/s40337-026-01771-y

Image Credits: AI Generated

DOI: 10.1186/s40337-026-01771-y

Keywords: anorexia nervosa, adapted physical activity, telehealth, videoconferencing, eating disorders, pilot study, quality of life, self-esteem, exercise dependence, outpatients, body composition, mental health